Colts GM Chris Ballard Disputes Alec Pierce PRP Reports Amid Ankle Rehab

Wide receiver Alec Pierce remains sidelined following offseason left ankle surgery as the Indianapolis Colts decline to set a firm return timeline.

Indianapolis Colts general manager Chris Ballard addressed the status of wide receiver Alec Pierce on Tuesday, August 11, 2026, confirming the wideout remains sidelined following offseason surgery on his left ankle. The 26-year-old pass-catcher is currently navigating a recovery process that has exceeded the initial 14-day estimation provided by the front office two weeks ago. Despite recent reports on Monday suggesting a new platelet-rich plasma (PRP) injection was administered to accelerate healing, Ballard clarified that the player only underwent PRP treatment in January. The Colts previously signed the receiver to a four-year, $114 million contract extension in March, positioning him as the primary target following the trade of Michael Pittman Jr.

Key details

Ballard explicitly denied claims that the athlete received a recent medical procedure to address his recovery. The general manager noted that the January treatment was the only instance of PRP usage, contradicting reports from sources cited by ESPN. While the executive had projected a return window that has since lapsed, the organization is now refusing to establish a definitive date for the receiver to rejoin active practice sessions. This cautious approach follows a 2025 campaign where the player struggled with persistent soreness in his lower leg and heel, eventually necessitating surgical intervention when non-invasive methods failed to provide relief.

The decision for the surgery followed a season where the wideout admitted to physical limitations during the month of June. Ballard described the current rehabilitation as having "ups and downs" and a "new normal," though he maintained that no specific setbacks have occurred during the summer months. The team is monitoring the player's response to increased workloads, noting that every individual body reacts differently to post-operative stress. The $114 million investment in the player underscores the importance of his health to the Indianapolis offensive scheme, which lacks veteran depth at the position following recent roster turnover.

Regarding the upcoming schedule, Ballard stated the expectation is for the receiver to be available for the regular season opener, though he characterized the situation as day-to-day. The Colts are currently engaged in joint practices and a preseason matchup against the New England Patriots, sessions which the injured wideout is watching from the sidelines. In other roster news, starting cornerback Charvarius Ward did not travel for these sessions, remaining in Indianapolis due to back soreness. The absence of these key starters has forced the coaching staff to elevate younger prospects during high-intensity drills against AFC East competition.

Latest developments

The wide receiver is expected to lead the receiving corps after the departure of Pittman Jr., making his recovery central to the 2026 offensive plans. Ballard maintained that the player is in good physical shape and making significant progress despite the lack of a specific return date. The front office remains optimistic that the surgical repair will resolve the chronic issues that hampered the player's production last year. During the 2025 season, the wideout's mobility was visibly impacted, leading to the eventual choice of a permanent fix over temporary injections.

Medical staff are focusing on the long-term stability of the left ankle rather than rushing a return for preseason exhibitions. The January PRP injection was intended to stimulate tissue repair, but the lack of desired results led to the operating table. Ballard emphasized that the current narrative surrounding a second injection is factually incorrect, stressing that the rehab is strictly focused on strength and flexibility milestones. The team's medical department is utilizing data-driven metrics to determine when the athlete can safely transition from individual drills to full-contact team periods.

As the regular season approaches, the pressure mounts for the Indianapolis offense to find rhythm without their top vertical threat. The trade of Pittman Jr. left a void that the organization believes the former second-round pick can fill, provided his ankle holds up under game conditions. Ballard's Tuesday press conference served as a firm rebuttal to external speculation regarding the player's health status. The general manager concluded by stating that the player's work ethic in the training room has been exemplary, even as the calendar moves closer to the September kickoff. The focus remains on ensuring the $114 million asset is fully functional for a 17-game stretch.